Skip to main content

CVA Family Office, LLC

Family Office

Position in GSK — GSK plc

CIK 1802084 DENVER, CO

Position in GSK

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$419,360
-$22,160 QoQ
Shares Held
8,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#516
of 1,033 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. GSK ranks #8 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GSK
GSK plc
This page
8,000 $419,360

All Filings in GSK

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $419,360 8,000
2026-03-31 $441,520 8,000
2025-12-31 $392,320 8,000
2025-09-30 $345,280 8,000
2025-06-30 $307,200 8,000
2025-03-31 $309,920 8,000
2024-12-31 $270,560 8,000
2024-09-30 $327,040 8,000
2024-06-30 $308,000 8,000
2024-03-31 $342,960 8,000
2023-12-31 $296,480 8,000
2023-09-30 $290,000 8,000
2023-06-30 $292,319 8,202
2023-03-31 $291,827 8,202
2022-12-31 $294,508 8,381
2022-09-30 $5,944 202
2022-06-30 $10,801 253
2022-03-31 $10,809 253
2021-12-31 $10,943 253
2021-06-30 $9,881 253